| Pay vs Performance Disclosure | 12 Months Ended |
| Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($) |
| Pay vs Performance Disclosure [Table] | | | |
| Pay vs Performance [Table Text Block] | Year Summary Compensation Table Total for PEO (1) Compensation Actually Paid to PEO (1)(2) Average Summary Compensation Table Total for Non-PEO NEOs (1) Average Compensation Actually Paid to Non-PEO NEOs (1)(2) Total Shareholder Return Peer Group Total Shareholder Return (3) Net Income (millions) Adjusted EBITDA % (4) 2022 $ 8,523,732 $ (4,535,253) $ 1,836,308 $ (42,128) $ 113.60 $ 140.29 $ 243.1 20.1 % 2021 $ 9,199,748 $ 28,844,127 $ 2,474,388 $ 4,661,522 $ 152.02 $ 143.09 $ 340.5 19.7 % 2020 $ 7,370,894 $ 14,441,335 $ 1,640,642 $ 2,321,660 $ 113.80 $ 113.45 $ 33.3 13.0 % | | |
| Company Selected Measure Name | adjusted EBITDA | | |
| Named Executive Officers, Footnote [Text Block] | The PEO for 2022, 2021 and 2020 was Amir Aghdaei. The non-PEO NEOs for 2022, 2021 and 2020 were Howard Yu (Senior Vice President and Chief Financial Officer), Jean-Claude Kyrillos (Senior Vice President of Diagnostics and Digital Solutions), Patrik Eriksson (Senior Vice President, President of Nobel Biocare), and Mark Nance (Senior Vice President, General Counsel and Secretary). | | |
| Peer Group Issuers, Footnote [Text Block] | Total shareholder return (“TSR”) is determined based on the value of an initial fixed investment of $100 on December 31, 2019. The Peer Group TSR set forth in this table utilizes the S&P 500 Health Care Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report on Form 10-K for the year ended December 31, 2022. Historical stock performance is not necessarily indicative of future stock performance. | | |
| PEO Total Compensation Amount | $ 8,523,732 | $ 9,199,748 | $ 7,370,894 |
| PEO Actually Paid Compensation Amount | $ (4,535,253) | 28,844,127 | 14,441,335 |
| Adjustment To PEO Compensation, Footnote [Text Block] | Equity award adjustments Year Executive(s) SCT Total Deduct grant date fair value of equity awards reported in SCT Add year-end value of unvested equity awards granted in year Change in value of unvested equity awards granted in prior years Change in value of equity awards granted in prior years which vested in year 2022 PEO $ 8,523,732 $ (5,100,321) $ 2,608,474 $ (11,166,139) $ 599,000 Non-PEO NEOs $ 1,836,308 $ (1,025,211) $ 537,397 $ (1,446,374) $ 55,752 2021 PEO $ 9,199,748 $ (4,700,022) $ 6,694,551 $ 14,514,792 $ 3,135,059 Non-PEO NEOs $ 2,474,388 $ (1,350,182) $ 2,029,238 $ 1,321,927 $ 186,151 2020 PEO $ 7,370,894 $ (4,500,157) $ 6,904,798 $ 5,224,388 $ (558,588) Non-PEO NEOs $ 1,640,642 $ (781,373) $ 1,198,887 $ 331,885 $ (68,381) | | |
| Non-PEO NEO Average Total Compensation Amount | $ 1,836,308 | 2,474,388 | 1,640,642 |
| Non-PEO NEO Average Compensation Actually Paid Amount | $ (42,128) | 4,661,522 | 2,321,660 |
| Adjustment to Non-PEO NEO Compensation Footnote [Text Block] | Equity award adjustments Year Executive(s) SCT Total Deduct grant date fair value of equity awards reported in SCT Add year-end value of unvested equity awards granted in year Change in value of unvested equity awards granted in prior years Change in value of equity awards granted in prior years which vested in year 2022 PEO $ 8,523,732 $ (5,100,321) $ 2,608,474 $ (11,166,139) $ 599,000 Non-PEO NEOs $ 1,836,308 $ (1,025,211) $ 537,397 $ (1,446,374) $ 55,752 2021 PEO $ 9,199,748 $ (4,700,022) $ 6,694,551 $ 14,514,792 $ 3,135,059 Non-PEO NEOs $ 2,474,388 $ (1,350,182) $ 2,029,238 $ 1,321,927 $ 186,151 2020 PEO $ 7,370,894 $ (4,500,157) $ 6,904,798 $ 5,224,388 $ (558,588) Non-PEO NEOs $ 1,640,642 $ (781,373) $ 1,198,887 $ 331,885 $ (68,381) | | |
| Compensation Actually Paid vs. Total Shareholder Return [Text Block] | Description of Relationship Between PEO and Other NEO Compensation Actually Paid, Company TSR, and Peer Group TSR The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our other NEOs, the Company’s cumulative TSR over the three most recently completed fiscal years, and the TSR of the S&P 500 Health Care Index over the same period. | | |
| Compensation Actually Paid vs. Net Income [Text Block] | Description of Relationship Between PEO and Other NEO Compensation Actually Paid and Net Income The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our other NEOs, and our Net Income during the three most recently completed fiscal years. | | |
| Compensation Actually Paid vs. Company Selected Measure [Text Block] | Description of Relationship Between PEO and Other NEO Compensation Actually Paid and Adjusted EBITDA Margin The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our other NEOs, and our adjusted EBITDA margin during the three most recently completed fiscal years. | | |
| Tabular List [Table Text Block] | • Core Sales Growth • Free Cash Flow | | |
| Total Shareholder Return Amount | $ 113.60 | 152.02 | 113.80 |
| Peer Group Total Shareholder Return Amount | 140.29 | 143.09 | 113.45 |
| Net Income (Loss) | $ 243,100,000 | $ 340,500,000 | $ 33,300,000 |
| Company Selected Measure Amount | 0.201 | 0.197 | 0.130 |
| PEO Name | Amir Aghdaei | | |
| Additional 402(v) Disclosure [Text Block] | The amounts shown in the Compensation Actually Paid columns have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table (“SCT”) Total with certain adjustments as described below. | | |
| Measure [Axis]: 1 | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Measure Name | Core Sales Growth | | |
| Non-GAAP Measure Description [Text Block] | We determined adjusted EBITDA margin, calculated consistent with how the Company reports adjusted EBITDA to the public, divided by the Company’s total net sales, to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and Non-PEO NEOs in 2022. This performance measure may not have been the most important financial performance measure for years 2021 and 2020, and we may determine a different financial performance measure to be the most important financial performance measure in future years. | | |
| Measure [Axis]: 2 | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Measure Name | Free Cash Flow | | |
| Measure [Axis]: 3 | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Measure Name | Adjusted EB | | |
| PEO [Member] | Equity Awards Granted During the Year, Vested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | $ (5,100,321) | $ (4,700,022) | $ (4,500,157) |
| PEO [Member] | Equity Awards Granted During the Year, Unvested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | 2,608,474 | 6,694,551 | 6,904,798 |
| PEO [Member] | Equity Awards Granted In Prior Years, Unvested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | (11,166,139) | 14,514,792 | 5,224,388 |
| PEO [Member] | Equity Awards Granted In Prior Years, Vested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | 599,000 | 3,135,059 | (558,588) |
| Non-PEO NEO [Member] | Equity Awards Granted During the Year, Vested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | (1,025,211) | (1,350,182) | (781,373) |
| Non-PEO NEO [Member] | Equity Awards Granted During the Year, Unvested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | 537,397 | 2,029,238 | 1,198,887 |
| Non-PEO NEO [Member] | Equity Awards Granted In Prior Years, Unvested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | (1,446,374) | 1,321,927 | 331,885 |
| Non-PEO NEO [Member] | Equity Awards Granted In Prior Years, Vested [Member] | | | |
| Pay vs Performance Disclosure [Table] | | | |
| Adjustment to Compensation Amount | $ 55,752 | $ 186,151 | $ (68,381) |
